The document describes the multi-stage drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, use of disease models in animals and cells, and clinical trials in humans. Key stages involve genomic and proteomic analysis to select drug targets, combinatorial chemistry and high-throughput screening to develop compound libraries, and refinement of lead candidates through medicinal chemistry, in vitro and in vivo studies.
Target selection lead discovery medicinal drug discovery process design 5 pow...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery process design 5 pow...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Drug discovery process style 5 powerpoint presentation slides db ppt templatesSlideTeam.net
The document outlines the key stages in the drug discovery process, including target selection, lead discovery, drug development, preclinical testing, and clinical trials. Genetic and cellular targets are identified through genomics and proteomics. Combinatorial chemistry and high-throughput screening are used to develop compound libraries and identify potential drug candidates. Lead compounds are refined through medicinal chemistry and testing in cellular and animal disease models. Top candidates then progress to clinical trials in humans to test for safety and efficacy.
Traditional drug discovery process design 6 powerpoint ppt slides.SlideTeam.net
The document describes two approaches to drug discovery: the traditional approach and the SWITCH drug re-profiling approach. The traditional approach involves lengthy timelines of 0.5-6 years across target identification, validation, lead identification, candidate optimization, pre-clinical trials, and clinical trials. The SWITCH approach aims to shorten timelines by mining existing drug data to identify new therapeutic uses for existing drugs and performing a clinical proof of concept trial within 0.5-1 year on a re-profiled drug.
Drug discovery process style 6 powerpoint presentation templatesSlideTeam.net
The document describes two approaches to drug discovery: traditional drug discovery and a SWITCH drug re-profiling approach. The traditional approach involves multiple sequential steps over 6-10 years, including target identification, validation, lead identification, candidate optimization, pre-clinical testing, and clinical trials. The SWITCH approach uses data mining to identify existing drugs that could be re-purposed for new indications, potentially shortening the process to just 0.5-1 years for target identification and proof-of-concept clinical trials on re-profiled drugs.
Drug discovery process style 5 powerpoint presentation templatesSlideTeam.net
The document describes the key stages in the drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, high-throughput screening, lead optimization, preclinical testing in animal models and in vitro/in vivo studies, and clinical trials in humans. The flow diagram shows the iterative process moving from early research to identify biological targets through compound development and testing, culminating in clinical evaluation and potential approval of new therapeutics.
How to make create genomic research target molecules drug discovery strategy ...SlideTeam.net
The drug discovery process involves several steps:
1) Identification of a biological target like receptors or enzymes.
2) Discovery of seed compounds that can bind to the target through high-throughput screening.
3) Scrutiny of potential drug candidates where their efficacy and safety are estimated.
How to make create genomic research target molecules drug discovery strategy ...SlideTeam.net
The document outlines the key steps in the drug discovery process:
1. Identification of target molecules through genomic research and functional analysis of genes and enzymes.
2. Discovery of seed lead compounds through high-throughput screening and combinatorial chemistry.
3. Scrutiny of drug candidates including estimation of drug efficacy and safety evaluation.
4. Manufacturing development and clinical studies prior to new drug application and launch.
Target selection lead discovery medicinal drug discovery process design 5 pow...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery process design 5 pow...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Drug discovery process style 5 powerpoint presentation slides db ppt templatesSlideTeam.net
The document outlines the key stages in the drug discovery process, including target selection, lead discovery, drug development, preclinical testing, and clinical trials. Genetic and cellular targets are identified through genomics and proteomics. Combinatorial chemistry and high-throughput screening are used to develop compound libraries and identify potential drug candidates. Lead compounds are refined through medicinal chemistry and testing in cellular and animal disease models. Top candidates then progress to clinical trials in humans to test for safety and efficacy.
Traditional drug discovery process design 6 powerpoint ppt slides.SlideTeam.net
The document describes two approaches to drug discovery: the traditional approach and the SWITCH drug re-profiling approach. The traditional approach involves lengthy timelines of 0.5-6 years across target identification, validation, lead identification, candidate optimization, pre-clinical trials, and clinical trials. The SWITCH approach aims to shorten timelines by mining existing drug data to identify new therapeutic uses for existing drugs and performing a clinical proof of concept trial within 0.5-1 year on a re-profiled drug.
Drug discovery process style 6 powerpoint presentation templatesSlideTeam.net
The document describes two approaches to drug discovery: traditional drug discovery and a SWITCH drug re-profiling approach. The traditional approach involves multiple sequential steps over 6-10 years, including target identification, validation, lead identification, candidate optimization, pre-clinical testing, and clinical trials. The SWITCH approach uses data mining to identify existing drugs that could be re-purposed for new indications, potentially shortening the process to just 0.5-1 years for target identification and proof-of-concept clinical trials on re-profiled drugs.
Drug discovery process style 5 powerpoint presentation templatesSlideTeam.net
The document describes the key stages in the drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, high-throughput screening, lead optimization, preclinical testing in animal models and in vitro/in vivo studies, and clinical trials in humans. The flow diagram shows the iterative process moving from early research to identify biological targets through compound development and testing, culminating in clinical evaluation and potential approval of new therapeutics.
How to make create genomic research target molecules drug discovery strategy ...SlideTeam.net
The drug discovery process involves several steps:
1) Identification of a biological target like receptors or enzymes.
2) Discovery of seed compounds that can bind to the target through high-throughput screening.
3) Scrutiny of potential drug candidates where their efficacy and safety are estimated.
How to make create genomic research target molecules drug discovery strategy ...SlideTeam.net
The document outlines the key steps in the drug discovery process:
1. Identification of target molecules through genomic research and functional analysis of genes and enzymes.
2. Discovery of seed lead compounds through high-throughput screening and combinatorial chemistry.
3. Scrutiny of drug candidates including estimation of drug efficacy and safety evaluation.
4. Manufacturing development and clinical studies prior to new drug application and launch.
The document describes the Institute for Cell Dynamics and Biotechnology, which conducts research in systems biology using a multidisciplinary approach. The key goals of the Institute are to conduct frontier research in cell function and dynamics using systems biology models, and to apply this research to important scientific and societal problems. It supports over 70 young researchers and postdocs and has an extensive international collaborations network. The research focuses on areas like metabolic networks, protein engineering, and metabolomics.
Representing Microarray Experiment Metadata Using Provenance ModelsJim McCusker
This document discusses representing experimental metadata as provenance using provenance models. It argues that experimental metadata is a type of provenance and evaluates mapping microarray metadata onto the Open Provenance Model and Proof Markup Language. It describes converting microarray data from MAGE-TAB format to RDF and then applying rules to generate equivalent provenance representations. Both OPM and PML are found to adequately represent the data, though some attributes are missing from each. Future work could integrate this provenance data with other systems and evaluate coverage on additional use cases.
Biotechnology Industry has changed a lot during last decade , which means moving ahead from traditional ways to more advanced technological developments
2012 Biotechnology Industry is not the same as it was in 2001
The document provides information about a bioinformatics lesson and exam. It states that there will be no lesson on December 4th. It then discusses the structure of the bioinformatics exam, which will randomly select images from a set of 713 images to display on a web page using JavaScript. The remainder of the document discusses various topics in comparative genomics, drug discovery, and other areas of bioinformatics.
Nuevos retos en la gestion de la identidad digital para la nueva generación d...Tomás García-Merás
Este documento proporciona una descripción general de la dirección de productos de una empresa. No constituye un compromiso legal para entregar funcionalidad y no debe ser utilizado para tomar decisiones de compra. El desarrollo y lanzamiento de características queda sujeto a la discreción de la empresa.
Uso de la firma en la AEAT (AEAT) - II Encuentro nacional sobre firma y admin...Tomás García-Merás
El documento describe el uso de la firma electrónica en la Agencia Estatal de Administración Tributaria (AEAT) en España. Se utilizan diferentes niveles de firma electrónica dependiendo del perfil del contribuyente. La firma electrónica avanzada representa el 84% de las presentaciones, mientras que el 6% usa firma electrónica no avanzada y el 4% presenta en papel. El objetivo es alcanzar el 100% de presentación electrónica usando firma avanzada para la mayoría y firma no avanzada solo con PIN24H
Circular Informativa, Pif Permiso Individual De FormacióNCarles Bonastre
El documento describe el permiso individual de formación (PIF), un permiso autorizado por la empresa para que un trabajador realice cursos de formación. La empresa puede bonificar hasta 200 horas por curso académico para los costes salariales del trabajador durante su formación. La formación debe estar reconocida oficialmente y ser presencial, y la empresa debe informar a los representantes de los trabajadores antes de conceder el permiso.
Certificados electrónicos en dispositivos móviles (FNMT-RCM) - II Encuentro n...Tomás García-Merás
El documento describe un nuevo proyecto de la Fábrica Nacional de Moneda y Timbre para permitir la firma electrónica desde dispositivos móviles. El proyecto utilizará el sistema operativo Android 4 debido a que es el más popular y cuenta con un almacén central de certificados. La aplicación permitirá generar claves de forma segura en el dispositivo, gestionar certificados de forma nativa, y realizar firmas electrónicas de manera asíncrona y sin necesidad de conexión.
Sistemas de autenticacion y firma en tráfico (DGT) - II Encuentro nacional so...Tomás García-Merás
Este documento resume un encuentro nacional sobre firma y administración electrónica organizado por la Dirección General de Tráfico (DGT) en octubre de 2013. Presenta estadísticas sobre conductores, vehículos y trámites gestionados por la DGT. Explica la política de firma electrónica y certificados de la DGT y su compatibilidad con la política marco de la Administración General del Estado. Finalmente, propone aplicar criterios de proporcionalidad en autenticación y firma para evitar problemas y ahorrar costes.
Drug discovery process style 3 powerpoint presentation templatesSlideTeam.net
The document summarizes the key steps in the drug discovery process. It involves:
1) Identifying a biological target molecule through genomic research and functional analysis of genes.
2) Discovering seed lead compounds through high-throughput screening and combinatorial chemistry.
3) Scrutinizing drug candidates through estimation of efficacy, safety evaluation, pharmacokinetics studies, and manufacturing development.
4) Conducting clinical studies and applying for a new drug approval.
Metabolomics is the newest hype in the 'omics' family. Although defined as highly important to recent biological research, the analytical science applied is far from acceptable for the majority of publications that appear nowadays. Take a look at our approach to tackle the metabolomics issue, which remains a new name for an old science.
This document discusses systems pharmacology and applying a systems-based approach to understanding drug action and effects. It begins by outlining some big questions in pharmacology research, such as predicting drug efficacy and toxicity. It then discusses concepts like polypharmacology, where one drug can have multiple targets, and how drug binding is a dynamic process. The document proposes using multiscale modeling to simulate these complex biological processes. It describes developing computational methods to explore the large conformational and functional spaces involved. Several applications of these approaches are mentioned, such as drug repositioning and designing personalized medicines. Overall, the document advocates applying systems-level modeling and simulations to better understand how drugs work in the body.
Biovays is a biomarker solutions provider that offers specialized services to support drug development from target discovery through FDA approval. Their services include biomarker selection and assay development, pharmacodynamics testing, toxicity analysis, and various in vitro and ex vivo assays. By providing biomarker analysis and expertise, Biovays aims to streamline drug development, reduce costs, and improve success rates.
GVK Biosciences (GVK BIO) offers screening services for drug discovery to determine biological activity and properties customized to meet the research needs of the Pharma and Biotech industries. Our range of assays include Biochemical, Cellular, ADME assays & Animal models for profiling of NCEs for Potency, Selectivity, Efficacy, Drugability and Toxicity.
Metin Bilgin is an experienced molecular and cellular biologist with over 12 years of postgraduate research experience. He co-developed the first proteome chip and assay protocols for protein array technology. His research has focused on studying cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor regulated drug metabolism through interactive proteomics, protein expression, and recombinant protein purification techniques. He holds a Ph.D. in Molecular and Cellular Biology from Szeged University and has worked in academic research positions in Turkey, Hungary, the UK, and the US.
Metin Bilgin is an experienced molecular and cellular biologist with over 12 years of postgraduate research experience. He co-developed the first proteome chip and assays for protein array technology. His research has focused on studying cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor-regulated drug metabolism. He is skilled in interactive proteomics, protein expression, purification of multi-protein complexes, and developing high-throughput molecular assays. Currently he works as a postdoctoral research associate at the University of Illinois studying regulation of cytochrome P450 activity by nuclear hormone receptor CAR.
This document provides an overview of the course Pharm 202 on Computer Aided Drug Design. It discusses the principles of drug discovery including modern target identification, lead identification, and data-driven approaches. The drug discovery process is outlined involving natural products, synthetic chemicals, and biologicals as starting points. Computer aided drug design has evolved from early visualization to modern automation and high-throughput approaches leveraging genomics, structural bioinformatics, and databases. The perspectives of targets, computers, and drugs in discovery are presented.
The document describes the Institute for Cell Dynamics and Biotechnology, which conducts research in systems biology using a multidisciplinary approach. The key goals of the Institute are to conduct frontier research in cell function and dynamics using systems biology models, and to apply this research to important scientific and societal problems. It supports over 70 young researchers and postdocs and has an extensive international collaborations network. The research focuses on areas like metabolic networks, protein engineering, and metabolomics.
Representing Microarray Experiment Metadata Using Provenance ModelsJim McCusker
This document discusses representing experimental metadata as provenance using provenance models. It argues that experimental metadata is a type of provenance and evaluates mapping microarray metadata onto the Open Provenance Model and Proof Markup Language. It describes converting microarray data from MAGE-TAB format to RDF and then applying rules to generate equivalent provenance representations. Both OPM and PML are found to adequately represent the data, though some attributes are missing from each. Future work could integrate this provenance data with other systems and evaluate coverage on additional use cases.
Biotechnology Industry has changed a lot during last decade , which means moving ahead from traditional ways to more advanced technological developments
2012 Biotechnology Industry is not the same as it was in 2001
The document provides information about a bioinformatics lesson and exam. It states that there will be no lesson on December 4th. It then discusses the structure of the bioinformatics exam, which will randomly select images from a set of 713 images to display on a web page using JavaScript. The remainder of the document discusses various topics in comparative genomics, drug discovery, and other areas of bioinformatics.
Nuevos retos en la gestion de la identidad digital para la nueva generación d...Tomás García-Merás
Este documento proporciona una descripción general de la dirección de productos de una empresa. No constituye un compromiso legal para entregar funcionalidad y no debe ser utilizado para tomar decisiones de compra. El desarrollo y lanzamiento de características queda sujeto a la discreción de la empresa.
Uso de la firma en la AEAT (AEAT) - II Encuentro nacional sobre firma y admin...Tomás García-Merás
El documento describe el uso de la firma electrónica en la Agencia Estatal de Administración Tributaria (AEAT) en España. Se utilizan diferentes niveles de firma electrónica dependiendo del perfil del contribuyente. La firma electrónica avanzada representa el 84% de las presentaciones, mientras que el 6% usa firma electrónica no avanzada y el 4% presenta en papel. El objetivo es alcanzar el 100% de presentación electrónica usando firma avanzada para la mayoría y firma no avanzada solo con PIN24H
Circular Informativa, Pif Permiso Individual De FormacióNCarles Bonastre
El documento describe el permiso individual de formación (PIF), un permiso autorizado por la empresa para que un trabajador realice cursos de formación. La empresa puede bonificar hasta 200 horas por curso académico para los costes salariales del trabajador durante su formación. La formación debe estar reconocida oficialmente y ser presencial, y la empresa debe informar a los representantes de los trabajadores antes de conceder el permiso.
Certificados electrónicos en dispositivos móviles (FNMT-RCM) - II Encuentro n...Tomás García-Merás
El documento describe un nuevo proyecto de la Fábrica Nacional de Moneda y Timbre para permitir la firma electrónica desde dispositivos móviles. El proyecto utilizará el sistema operativo Android 4 debido a que es el más popular y cuenta con un almacén central de certificados. La aplicación permitirá generar claves de forma segura en el dispositivo, gestionar certificados de forma nativa, y realizar firmas electrónicas de manera asíncrona y sin necesidad de conexión.
Sistemas de autenticacion y firma en tráfico (DGT) - II Encuentro nacional so...Tomás García-Merás
Este documento resume un encuentro nacional sobre firma y administración electrónica organizado por la Dirección General de Tráfico (DGT) en octubre de 2013. Presenta estadísticas sobre conductores, vehículos y trámites gestionados por la DGT. Explica la política de firma electrónica y certificados de la DGT y su compatibilidad con la política marco de la Administración General del Estado. Finalmente, propone aplicar criterios de proporcionalidad en autenticación y firma para evitar problemas y ahorrar costes.
Drug discovery process style 3 powerpoint presentation templatesSlideTeam.net
The document summarizes the key steps in the drug discovery process. It involves:
1) Identifying a biological target molecule through genomic research and functional analysis of genes.
2) Discovering seed lead compounds through high-throughput screening and combinatorial chemistry.
3) Scrutinizing drug candidates through estimation of efficacy, safety evaluation, pharmacokinetics studies, and manufacturing development.
4) Conducting clinical studies and applying for a new drug approval.
Metabolomics is the newest hype in the 'omics' family. Although defined as highly important to recent biological research, the analytical science applied is far from acceptable for the majority of publications that appear nowadays. Take a look at our approach to tackle the metabolomics issue, which remains a new name for an old science.
This document discusses systems pharmacology and applying a systems-based approach to understanding drug action and effects. It begins by outlining some big questions in pharmacology research, such as predicting drug efficacy and toxicity. It then discusses concepts like polypharmacology, where one drug can have multiple targets, and how drug binding is a dynamic process. The document proposes using multiscale modeling to simulate these complex biological processes. It describes developing computational methods to explore the large conformational and functional spaces involved. Several applications of these approaches are mentioned, such as drug repositioning and designing personalized medicines. Overall, the document advocates applying systems-level modeling and simulations to better understand how drugs work in the body.
Biovays is a biomarker solutions provider that offers specialized services to support drug development from target discovery through FDA approval. Their services include biomarker selection and assay development, pharmacodynamics testing, toxicity analysis, and various in vitro and ex vivo assays. By providing biomarker analysis and expertise, Biovays aims to streamline drug development, reduce costs, and improve success rates.
GVK Biosciences (GVK BIO) offers screening services for drug discovery to determine biological activity and properties customized to meet the research needs of the Pharma and Biotech industries. Our range of assays include Biochemical, Cellular, ADME assays & Animal models for profiling of NCEs for Potency, Selectivity, Efficacy, Drugability and Toxicity.
Metin Bilgin is an experienced molecular and cellular biologist with over 12 years of postgraduate research experience. He co-developed the first proteome chip and assay protocols for protein array technology. His research has focused on studying cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor regulated drug metabolism through interactive proteomics, protein expression, and recombinant protein purification techniques. He holds a Ph.D. in Molecular and Cellular Biology from Szeged University and has worked in academic research positions in Turkey, Hungary, the UK, and the US.
Metin Bilgin is an experienced molecular and cellular biologist with over 12 years of postgraduate research experience. He co-developed the first proteome chip and assays for protein array technology. His research has focused on studying cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor-regulated drug metabolism. He is skilled in interactive proteomics, protein expression, purification of multi-protein complexes, and developing high-throughput molecular assays. Currently he works as a postdoctoral research associate at the University of Illinois studying regulation of cytochrome P450 activity by nuclear hormone receptor CAR.
This document provides an overview of the course Pharm 202 on Computer Aided Drug Design. It discusses the principles of drug discovery including modern target identification, lead identification, and data-driven approaches. The drug discovery process is outlined involving natural products, synthetic chemicals, and biologicals as starting points. Computer aided drug design has evolved from early visualization to modern automation and high-throughput approaches leveraging genomics, structural bioinformatics, and databases. The perspectives of targets, computers, and drugs in discovery are presented.
Metin Bilgin is a molecular and cellular biologist with over 12 years of postgraduate research experience. He has expertise in proteomics, protein expression, and characterization. Some of his accomplishments include co-developing the first proteome chip and establishing HTP assay protocols for protein array technology. He has studied various topics like cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor regulated drug metabolism. Currently, he is a postdoctoral research associate studying regulation of cytochrome P450 activity by nuclear hormone receptor CAR. He aims to work for a leading life sciences research company focused on discovery and translational medicine.
Presentation given as part of the EMBO Workshop on Plant-Microbe Interactions, at The Sainsbury Laboratory, Norwich, 20th June 2012. This presentation describes bioinformatic and statistical considerations for the prediction of plant pathogen effectors from genome sequences and annotation, with several literature examples.
This document discusses the evolution of systems biology and its various approaches over time, such as genomic and proteomic profiling, molecular interaction networks, disease models, and drug trials. It notes the movement from studying individual components to constructing network models of entire biological systems and pathways. It also addresses challenges like overgeneralizing findings and the need for more collaborative and open research.
Dr. M. N. Astagimath's presentation discusses genomics, proteomics, and metabolomics. The objectives are to understand the concepts and define each term. Genomics is the study of genomes and involves functional, structural, and epigenomics. Proteomics is the large-scale study of proteins and involves expression, interaction, and biomarker analysis. Metabolomics is the study of small molecule metabolites and their profiles can provide unique fingerprints of cellular processes. A variety of methods are used in each field like sequencing and mass spectrometry. The data has applications in medicine such as diagnosis, risk assessment, and bioengineering.
Similar to Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint ppt slides. (14)
Business powerpoint presentations process diagram six decisions cycle flow ch...SlideTeam.net
The document describes how to edit and customize a business process diagram template in PowerPoint. It includes 6 steps represented by diverging arrows. At each step, text or images can be added and modified. All images are fully editable in terms of color, size, orientation, and other properties using the formatting and drawing tools in PowerPoint. This allows the template to be customized while maintaining a consistent visual structure.
Powerpoint presentations process management solution cycle flow network templ...SlideTeam.net
The document describes a 7 step converging arrows business process management solution. It includes 7 steps represented by arrows that converge on a central text box. All images are 100% editable in PowerPoint and allow the user to change color, size, orientation or any icon to their liking. The document also provides instructions on how to ungroup objects and edit their color using theme colors or by selecting fill and solid options.
Group of nine coverging arrows circular layout process power point slidesSlideTeam.net
The document describes how to edit a group of nine converging arrows diagram in PowerPoint. It includes instructions on ungrouping the object, editing the color, and editing the color by theme colors. The diagram can be customized by changing the color, size, and orientation of any icon. All images are fully editable in PowerPoint.
Four leading reason for cause cycle process diagram power point slidesSlideTeam.net
The document discusses editing images in PowerPoint. It provides instructions on how to ungroup objects, edit colors, and change colors using theme colors. The key steps are to right click objects to ungroup or access formatting options, select fill and color options to change the appearance, and choose from built-in theme colors.
To good world business powerpoint templates ideas processs andSlideTeam.net
The document contains instructions for editing business diagram images in PowerPoint. It explains how to ungroup objects, edit colors, and change colors using built-in theme colors. The purpose is to allow users to customize diagram images for business presentations.
Three converging arrows managing process layout cycle network power point slidesSlideTeam.net
The document describes how to edit icons in a PowerPoint presentation. It provides instructions on ungrouping objects, changing colors, and using theme colors. The steps include right clicking objects, choosing format options, and selecting fill and color options. The overall purpose is to demonstrate how to customize icons and make images fully editable.
Six coverging arrows for process to carried out charts and power point slidesSlideTeam.net
The document describes how to edit a diagram template with six converging arrows. Key points:
- The template can be used to bring presentations to life and capture audiences' attention.
- All images are 100% editable in PowerPoint, allowing the user to change color, size, and orientation of any icon.
- To ungroup objects, right click, select "Ungroup", and drag the selection arrow over parts to edit individually.
- To change an object's color, right click it, select "Format Shape", and choose a "Fill" color or gradient from the options provided. Colors can also be changed using the built-in theme colors.
Powerpoint presentations process management solution cycle flow network templ...SlideTeam.net
The document describes a 7 step converging arrows business process management solution. It includes 7 steps represented by arrows that converge on a central text box. All images are 100% editable in PowerPoint and allow the user to change color, size, orientation or any icon to their liking. The document also provides instructions on how to ungroup objects and edit their color using theme colors or by selecting fill and solid options.
Diverging arrows pointing specific directions processs and power point templatesSlideTeam.net
The document shows a diagram with diverging arrows pointing in different directions. The arrows can be edited in PowerPoint by ungrouping the object, changing the color using the format shape option or theme colors, and dragging the arrow to change its orientation. The diagram brings presentations to life and captures audiences' attention. It is fully editable and customizable in PowerPoint.
Templates process diagram with diverging arrows circular layout power point s...SlideTeam.net
The document is an illustration of a business process diagram with diverging arrows. It shows a process splitting into multiple parallel processes represented by arrows branching in different directions. All images in the diagram are fully editable in PowerPoint and can be modified by changing properties like color, size, and orientation. The document provides instructions on how to perform actions like ungrouping objects and editing colors using options in the PowerPoint interface.
Steps layout with converging arrows pointing to center cycle process power po...SlideTeam.net
The document describes how to edit icons in a PowerPoint presentation. It provides instructions for ungrouping objects, editing colors, and changing colors using built-in theme colors. The steps allow presenters to customize icons by changing their size, orientation, and colors to suit their liking.
Seven factors arrow pointing business process charts and power point slidesSlideTeam.net
The document appears to be a template for a diagram or presentation with 7 factors pointing to a central business process. The template includes placeholder text and images that can be customized. It is meant to bring presentations to life and capture audience attention. All elements are editable in PowerPoint.
Diverging arrows pointing different directions circular motion network power ...SlideTeam.net
The document shows a diagram template with diverging arrows pointing in different directions. The template can be customized with text in 8 boxes to bring presentations to life and capture audience attention. The images are fully editable in PowerPoint.
Diverging arrow process project activity diagram cycle power point slidesSlideTeam.net
The document describes a diverging arrow process project activity diagram. It includes steps numbered 1 through 5 with arrows connecting each step. Text placeholders throughout suggest editing the text to describe your own process. The document encourages downloading the diagram and editing it in PowerPoint to bring your own presentation to life and capture your audience's attention. It specifies that all images are 100% editable in terms of color, size, orientation, and text.
Diverging arrow pointing strategic planning process arrows network software p...SlideTeam.net
The document describes a diverging arrow diagram for strategic planning. It includes 11 points labeled 1 through 11 with arrows pointing in different directions. Below the diagram are bullet points describing how the diagram can be used to bring presentations to life, capture audiences' attention, and is fully editable in PowerPoint by changing colors, sizes, orientations of icons, ungrouping objects, and editing colors using theme colors. The document provides instructions for customizing a diverging arrow diagram template for strategic planning presentations.
Diverging arrows graphical view of different aspects cycle flow chart power p...SlideTeam.net
The document describes how to edit and customize diverging arrow diagrams created in PowerPoint. It includes 6 arrows branching from a central point and labeled text boxes that can be edited. The summary provides instructions on how to:
1. Ungroup individual elements to edit them separately.
2. Change colors by right clicking, selecting format shape, and choosing a solid or gradient fill color.
3. Change colors using built-in theme colors under the Design tab.
Diverging arrow pointing strategic planning process arrows network software p...SlideTeam.net
The document describes a diverging arrow diagram for strategic planning. It includes placeholders for text and logos. The diagram has 11 points connected by arrows and can be edited in PowerPoint. It is meant to help presentations and capture audience attention.
Business powerpoint presentations process diagram six decisions cycle flow ch...SlideTeam.net
The document shows a diverging arrows business process diagram with 6 decision points. The diagram can be edited in PowerPoint by changing the text, ungrouping objects to edit individual parts, and changing colors. All images are fully editable and the diagram is meant to capture audience attention and bring presentations to life.
Business powerpoint templates download process diagram cycleSlideTeam.net
The document is a 9 step converging arrows business process diagram template that allows users to customize each step with text and download the finished diagram. It provides an editable template to create a process flow chart for presentations.
Arrow diagram shows required order of tasks arrows software power point templ...SlideTeam.net
The document describes how to edit an arrow diagram in PowerPoint. It outlines the following steps:
1. Ungroup the object by right clicking, selecting group, and then ungroup to edit individual elements.
2. Edit the color of shapes by right clicking, selecting format shape, and choosing a solid or gradient fill color from the options.
3. Alternatively, colors can be changed by selecting a shape and choosing from the built-in theme colors in the design tab.
Best practices for project execution and deliveryCLIVE MINCHIN
A select set of project management best practices to keep your project on-track, on-cost and aligned to scope. Many firms have don't have the necessary skills, diligence, methods and oversight of their projects; this leads to slippage, higher costs and longer timeframes. Often firms have a history of projects that simply failed to move the needle. These best practices will help your firm avoid these pitfalls but they require fortitude to apply.
The Steadfast and Reliable Bull: Taurus Zodiac Signmy Pandit
Explore the steadfast and reliable nature of the Taurus Zodiac Sign. Discover the personality traits, key dates, and horoscope insights that define the determined and practical Taurus, and learn how their grounded nature makes them the anchor of the zodiac.
Industrial Tech SW: Category Renewal and CreationChristian Dahlen
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
3 Simple Steps To Buy Verified Payoneer Account In 2024SEOSMMEARTH
Buy Verified Payoneer Account: Quick and Secure Way to Receive Payments
Buy Verified Payoneer Account With 100% secure documents, [ USA, UK, CA ]. Are you looking for a reliable and safe way to receive payments online? Then you need buy verified Payoneer account ! Payoneer is a global payment platform that allows businesses and individuals to send and receive money in over 200 countries.
If You Want To More Information just Contact Now:
Skype: SEOSMMEARTH
Telegram: @seosmmearth
Gmail: seosmmearth@gmail.com
Navigating the world of forex trading can be challenging, especially for beginners. To help you make an informed decision, we have comprehensively compared the best forex brokers in India for 2024. This article, reviewed by Top Forex Brokers Review, will cover featured award winners, the best forex brokers, featured offers, the best copy trading platforms, the best forex brokers for beginners, the best MetaTrader brokers, and recently updated reviews. We will focus on FP Markets, Black Bull, EightCap, IC Markets, and Octa.
Digital Marketing with a Focus on Sustainabilitysssourabhsharma
Digital Marketing best practices including influencer marketing, content creators, and omnichannel marketing for Sustainable Brands at the Sustainable Cosmetics Summit 2024 in New York
[To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
This presentation is a curated compilation of PowerPoint diagrams and templates designed to illustrate 20 different digital transformation frameworks and models. These frameworks are based on recent industry trends and best practices, ensuring that the content remains relevant and up-to-date.
Key highlights include Microsoft's Digital Transformation Framework, which focuses on driving innovation and efficiency, and McKinsey's Ten Guiding Principles, which provide strategic insights for successful digital transformation. Additionally, Forrester's framework emphasizes enhancing customer experiences and modernizing IT infrastructure, while IDC's MaturityScape helps assess and develop organizational digital maturity. MIT's framework explores cutting-edge strategies for achieving digital success.
These materials are perfect for enhancing your business or classroom presentations, offering visual aids to supplement your insights. Please note that while comprehensive, these slides are intended as supplementary resources and may not be complete for standalone instructional purposes.
Frameworks/Models included:
Microsoft’s Digital Transformation Framework
McKinsey’s Ten Guiding Principles of Digital Transformation
Forrester’s Digital Transformation Framework
IDC’s Digital Transformation MaturityScape
MIT’s Digital Transformation Framework
Gartner’s Digital Transformation Framework
Accenture’s Digital Strategy & Enterprise Frameworks
Deloitte’s Digital Industrial Transformation Framework
Capgemini’s Digital Transformation Framework
PwC’s Digital Transformation Framework
Cisco’s Digital Transformation Framework
Cognizant’s Digital Transformation Framework
DXC Technology’s Digital Transformation Framework
The BCG Strategy Palette
McKinsey’s Digital Transformation Framework
Digital Transformation Compass
Four Levels of Digital Maturity
Design Thinking Framework
Business Model Canvas
Customer Journey Map
Call8328958814 satta matka Kalyan result satta guessing➑➌➋➑➒➎➑➑➊➍
Satta Matka Kalyan Main Mumbai Fastest Results
Satta Matka ❋ Sattamatka ❋ New Mumbai Ratan Satta Matka ❋ Fast Matka ❋ Milan Market ❋ Kalyan Matka Results ❋ Satta Game ❋ Matka Game ❋ Satta Matka ❋ Kalyan Satta Matka ❋ Mumbai Main ❋ Online Matka Results ❋ Satta Matka Tips ❋ Milan Chart ❋ Satta Matka Boss❋ New Star Day ❋ Satta King ❋ Live Satta Matka Results ❋ Satta Matka Company ❋ Indian Matka ❋ Satta Matka 143❋ Kalyan Night Matka..
Profiles of Iconic Fashion Personalities.pdfTTop Threads
The fashion industry is dynamic and ever-changing, continuously sculpted by trailblazing visionaries who challenge norms and redefine beauty. This document delves into the profiles of some of the most iconic fashion personalities whose impact has left a lasting impression on the industry. From timeless designers to modern-day influencers, each individual has uniquely woven their thread into the rich fabric of fashion history, contributing to its ongoing evolution.
HOW TO START UP A COMPANY A STEP-BY-STEP GUIDE.pdf46adnanshahzad
How to Start Up a Company: A Step-by-Step Guide Starting a company is an exciting adventure that combines creativity, strategy, and hard work. It can seem overwhelming at first, but with the right guidance, anyone can transform a great idea into a successful business. Let's dive into how to start up a company, from the initial spark of an idea to securing funding and launching your startup.
Introduction
Have you ever dreamed of turning your innovative idea into a thriving business? Starting a company involves numerous steps and decisions, but don't worry—we're here to help. Whether you're exploring how to start a startup company or wondering how to start up a small business, this guide will walk you through the process, step by step.
The Most Inspiring Entrepreneurs to Follow in 2024.pdfthesiliconleaders
In a world where the potential of youth innovation remains vastly untouched, there emerges a guiding light in the form of Norm Goldstein, the Founder and CEO of EduNetwork Partners. His dedication to this cause has earned him recognition as a Congressional Leadership Award recipient.
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...APCO
The Radar reflects input from APCO’s teams located around the world. It distils a host of interconnected events and trends into insights to inform operational and strategic decisions. Issues covered in this edition include:
Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint ppt slides.
1. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
www.slideteam.net Your logo
2. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
3. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
4. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
5. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
6. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
7. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
8. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
9. All images are 100% editable in Powerpoint
“Change color, size and orientation of any icon to your liking”
www.slideteam.net
10. Ungrouping the object
2
1
3
1. Right click the object.
2. Choose Group and then Ungroup.
3. Click beside the object and drag the arrow over it.
www.slideteam.net
11. Edit Color
2 3
1
1. Select the shape to change the color and Right click the object( click any object which you
want to change color)
2. Choose Format Shape in the dialog box.
3. Choose “Fill” in the Format Shape box then “Solid” or “Gradient” depending on the
appearance of the object. Change colour as shown in the picture.
www.slideteam.net